Giuseppe Procopio
Giuseppe Procopio is the Head of Genitourinary Medical Oncology at the IRCCS National Cancer Institute in Milan, Italy. He is a recognized expert in the treatment of prostate cancer, particularly in the development and application of targeted therapies. Procopio has been at the forefront of introducing novel treatments, such as radioligands, which offer new hope for advanced prostate cancer patients, aiming to enhance both survival rates and quality of life.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 7.00 | 0.09% | +0% | 60,461,826 | 54,032 | $2,000,000 | 1,787$ |
| Totals | 1 | 60,461,826 | 54,032 | $2,000,000 | 1,787$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Giuseppe Procopio explained the PSA test and its significance in prostate cancer detection.
7
Italy:
Giuseppe Procopio is the director of the Prostate and Genitourinary Medical Oncology Program at the National Cancer Institute in Milan.
9
Italy:
Giuseppe Procopio is the director of the Prostate Program and Medical Oncology at the National Cancer Institute of Milan.
8
Italy:
Giuseppe Procopio is responsible for Medical Oncology at the Genitourinary Foundation IRCCS National Cancer Institute in Milan.
8